成功談 02.05.2024 BeiGeneがグローバルながん治療へのアクセスをどのように推進しているか スイスのバーゼルにある欧州本部を拠点に、BeiGeneは世界中の関係者と 戦略的に協力し、腫瘍学の研究開発を推進しています。同社は、 40か国で商業活動を展開し、45か国以上で臨床試験を実施しています。 Sirpa ...
News 11.10.2023 LimmaTech Biologics secures fresh capital of 37 million US dollars LimmaTech Biologics has raised 37 million US dollars as part of a Series A financing round. This should allow the company to finance the further ...
Actualités 12.01.2022 ObsEva obtient des résultats positifs dans le traitement de l’endométriose Spécialisée dans la santé des femmes, la société biopharmaceutique genevoise ObsEva a annoncé des résultats préliminaires positifs de l'essai de ...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22.10.2024–24.10.2024 Malham Саудовская Аравия
News 14.02.2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
Aktuell 11.10.2023 LimmaTech Biologics nimmt 37 Millionen Dollar ein LimmaTech Biologics nimmt in einer Serie A-Finanzierungsrunde 37 Millionen Dollar ein. Damit soll die weitere Entwicklung der Impfstoff-Pipeline ...
News 12.01.2022 ObsEva achieves positive results in the treatment of endometriosis Geneva-based women’s health biopharmaceutical company ObsEva has announced positive topline results from the Phase 3 EDELWEISS 3 trial of linzago...
Actualités 18.03.2024 Neuria intègre l’accélérateur Vanguard pour promouvoir des modes de vie plus sains Neuria Digital Therapeutics est la première start-up de 2024 à bénéficier du programme Vanguard Accelerator.
News 16.08.2023 Spexis receives capital commitment of 2.5 million US dollars Investors have made an additional capital commitment to Spexis AG. With an extra 2.5 million US dollars at its disposal, the biopharmaceutical fi...
News 08.08.2023 Do Tank Aargau aims to strengthen life sciences sector The pilot project Do Tank Aargau is being launched by the canton of Aargau, the city of Baden and Baden Cantonal Hospital (KSB) with the aim of s...
Actualités 14.02.2024 L’Université de Fribourg découvre un traitement pour combattre la neuroinflammation liée à l’âge Des scientifiques de l’Université de Fribourg ont découvert un mécanisme révolutionnaire qui pourrait atténuer de manière significative la neuroi...
News 24.05.2024 Health Innovation Hub drives medical innovation Switzerland Innovation Park East has opened its Health Innovation Hub in St.Gallen. The hub serves as a platform for initiating, promoting and ac...
Aktuell 22.01.2024 DISCO Pharmaceuticals startet mit 20 Millionen Euro Kapital DISCO Pharmaceuticals ist mit einem Startkapital von 20 Millionen Euro neu auf dem Markt. Sein Team hat als erstes eine Methode entwickelt, die e...
News 21.05.2024 InSphero partners with Genome Biologics The biotech company InSphero has signed an agreement with Genome Biologics to commercialize the 3D Cardiac Organoid Platform. The platform is at ...
News 29.01.2024 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
Aktuell 16.08.2023 Spexis erhält Kapitalzusage in Höhe von 2,5 Millionen Dollar Investoren lassen der Spexis AG weitere Investitionen zukommen. Mit zusätzlichen 2,5 Millionen Dollar will das biopharmazeutische Unternehmen die...